Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5452 participants.

Also called NCT06225752

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 5,452 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06225752
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06225752. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-15 (actual); primary completion 2028-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
Intervention (Drug)
Probucol
Intervention (Drug)
Placebo probucol
Lead sponsor
First Affiliated Hospital of Wannan Medical College (class: other)
Collaborator
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct06225752
Content hash
458851f2b4ad4c3ae3070d75316d3f9c7c6811fc8dc18348a9badc2619a8ca77